Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clinigence Holdings Inc (NUTX)
:NUTX
RESEARCH TOOLSreports
Holding NUTX?
Track your performance easily
NUTX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.16 - $41.44
Previous CloseN/A
Volume3.28K
Average Volume (3M)36.10K
Market Cap
$172.30M
Enterprise Value$386.34M
Total Cash (Recent Filing)$10.52K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.45
Next Earnings
Feb 27, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.86
Shares Outstanding5,437,003
10 Day Avg. Volume21,638
30 Day Avg. Volume36,099
Standard Deviation0.45
R-Squared0.06
Alpha-0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.62
Price to Cash Flow (P/CF)6.70
P/FCF Ratio2.10
Enterprise Value/Market Cap2.24
Enterprise Value/Revenue1.36
Enterprise Value/Gross Profit11.11
Enterprise Value/Ebitda11.20
Forecast
1Y Price Target
$55.33Price Target Upside74.60% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Clinigence Holdings News
PremiumCompany Announcements
Nutex Health Reports Strong Revenue Growth in Q3 2024
NUTX FAQ
What was Clinigence Holdings Inc’s price range in the past 12 months?
Clinigence Holdings Inc lowest stock price was $4.16 and its highest was $41.44 in the past 12 months.
What is Clinigence Holdings Inc’s market cap?
Clinigence Holdings Inc’s market cap is $172.30M.
When is Clinigence Holdings Inc’s upcoming earnings report date?
Clinigence Holdings Inc’s upcoming earnings report date is Feb 27, 2025 which is in 48 days.
How were Clinigence Holdings Inc’s earnings last quarter?
Clinigence Holdings Inc released its earnings results on Nov 07, 2024. The company reported -$1.72 earnings per share for the quarter, missing the consensus estimate of -$0.24 by -$1.48.
Is Clinigence Holdings Inc overvalued?
According to Wall Street analysts Clinigence Holdings Inc’s price is currently Undervalued.
Does Clinigence Holdings Inc pay dividends?
Clinigence Holdings Inc does not currently pay dividends.
What is Clinigence Holdings Inc’s EPS estimate?
Clinigence Holdings Inc’s EPS estimate is -0.12.
How many shares outstanding does Clinigence Holdings Inc have?
Clinigence Holdings Inc has 5,437,003 shares outstanding.
What happened to Clinigence Holdings Inc’s price movement after its last earnings report?
Clinigence Holdings Inc reported an EPS of -$1.72 in its last earnings report, missing expectations of -$0.24. Following the earnings report the stock price went up 9.242%.
Which hedge fund is a major shareholder of Clinigence Holdings Inc?
Currently, no hedge funds are holding shares in NUTX
---
Clinigence Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$55.33 (74.60% Upside)
$55.33 (74.60% Upside)
Blogger Sentiment
Bullish
NUTX Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 33.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 15.1%
Last 30 Days ▼ 15.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.97%
12-Months-Change
Fundamentals
Return on Equity
-54.71%
Trailing 12-Months
Asset Growth
-8.58%
Trailing 12-Months
Company Description
Clinigence Holdings Inc
Clinigence Holdings, Inc. is a healthcare information technology company. It provides cloud-based platform that enables healthcare organizations to provide value-based care and population health management. The company was founded in 2018 and is headquartered in Atlanta, GA.
---
NUTX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with notable revenue and EBITDA growth, alongside improvements in operational efficiency and cash flow. However, challenges remain with increased net losses and a decline in the Population Health division revenue. The company's strategic initiatives and cost control measures show promise for future performance.Read More>---
NUTX Stock 12 Month Forecast
Average Price Target
$55.33
▲(74.60% Upside)
Technical Analysis
Sunshine Biopharma
―
Genprex
―
Aditxt, Inc.
―
Histogen
―
Moleculin Biotech
―
Lineage Therap
―
Best Analysts Covering NUTX
1 Year
1 Year Success Rate
3/9 ratings generated profit
1 Year Average Return
+12.37%
assigned a buy rating 2 months ago
Copying Bill Sutherland's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +12.37% per trade.
---